Haemoglobinopathies congenital Enrolling by Invitation Phase 1 / 2 Trials for Rimiducid (DB04974)

Also known as: Haemoglobinopathies / Haemoglobinopathy / Hemoglobinopathy / Hemoglobinopathies / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Enrolling by Invitation1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03733249Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyTreatment